Arras, France

Agnès Guigueno

This inventor holds 1 USPTO granted patent. Top assignee: Institut Pasteur. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Agnès Guigueno. Retrieved from https://idiyas.com/inventor/agnès-guigueno

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Agnès Guigueno: Innovator in Mycobacterial Research

Introduction

Agnès Guigueno is a notable inventor based in Arras, France. He has made significant contributions to the field of mycobacterial research, particularly in the development of diagnostic and therapeutic methods for tuberculosis.

Latest Patents

Agnès Guigueno holds a patent for "Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis." This invention involves recombinant vectors replicated in mycobacteria, which include a set of sequences coding for exported polypeptides. One notable polypeptide, called DP428, corresponds to an exported protein found in mycobacteria. The invention also encompasses methods and kits for detecting the presence of mycobacteria in biological samples, as well as immunogenic or vaccine compositions aimed at preventing and treating infections caused by these bacteria.

Career Highlights

Agnès Guigueno is affiliated with the prestigious Institut Pasteur, where he continues to advance research in infectious diseases. His work has been instrumental in understanding the mechanisms of mycobacterial infections and developing innovative solutions to combat them.

Collaborations

He has collaborated with esteemed colleagues such as Brigitte Gicquel and Denis Portnoï, contributing to a rich environment of scientific inquiry and innovation.

Conclusion

Agnès Guigueno's work exemplifies the intersection of innovation and public health, particularly in the fight against tuberculosis. His contributions are vital for advancing our understanding and treatment of mycobacterial diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…